Sign Up to like & get
recommendations!
1
Published in 2017 at "Respiratory Care"
DOI: 10.4187/respcare.05360
Abstract: Inhaled nitric oxide (INO) is only FDA-cleared for neonates (> 34 weeks gestation) with hypoxic respiratory failure-associated pulmonary hypertension. Off-label use of INO is common in the pediatric population despite a lack of evidence regarding…
read more here.
Keywords:
vasodilators indications;
indications within;
inhaled pulmonary;
pediatric icu ... See more keywords